RT Journal Article
SR Electronic
T1 Razoxane - a new anti-tumour agent
JF Drug and Therapeutics Bulletin
JO Drug Ther Bull
FD BMJ Publishing Group Ltd
SP 7
OP 8
DO 10.1136/dtb.16.2.7
VO 16
IS 2
YR 1978
UL http://dtb.bmj.com/content/16/2/7.abstract
AB Razoxane (Razoxin - ICI; ICRF 159) is a new anti-tumour drug which is claimed to be well tolerated, to possess unusual modes of action and to increase the effectiveness of radiotherapy.